CYTO

Altamira Therapeutics Announces Transition From Nasdaq to Otc Markets

时间:2024-12-20 21:00:01 市场: 美股 综合

关联: NDAQ CYTO

Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering

时间:2024-09-18 05:00:06 市场: 美股 综合

关联: CYTO

Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement With Nuance Pharma in East and South East Asia

时间:2024-09-16 20:30:00 市场: 美股 综合

关联: CYTO